Upcoming Medical Conferences in MassachusettsSearch Criteria : United States of America
May 26 - 30, 2019 | Boston, Massachusetts
AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics is organized by American Association for Cancer Research (AACR) and will be held from Oct 26 - 30, 2019 at Hynes Convention Center, Boston, Massachusetts, United States of America. Additional details will be posted as soon as they are available.
May 28, 2019 | Boston, Massachusetts
ACRM-2 is organized by Center for Medical Simulation (CMS) and will be held on May 28, 2019 at Center For Medical Simulation, Boston, Massachusetts, United States of America. The target audience for this medical event is Anesthesiologists. Additional details will be posted as soon as they are available.
May 28 - 29, 2019 | USD $1895 | Boston, Massachusetts
Inhalation Drug Delivery Systems 2019 is organized by PharmaEd Resources, Inc and will be held from May 28 - 29, 2019 at Metro Meeting Centers-Boston, Boston, Massachusetts, United States of America. Featuring In-Depth Coverage On: • Regulatory Compliance Issues for Inhalation Therapies • Combination Product Design • Achieving An Inhaled Insulin Product • Developing A Generic Inhaled Product • Sterilization Issues Surrounding Inhalation Therapies • Extractables and Leachables Testing • Nebulizers, E-Cigarettes and Vaporizers: Past, present and future • Alternative Therapeutic Fields: Inhaled Antibiotics • Future directions in inhalation and respiratory drug delivery research • Novel Technologies For Pulmonary And Nasal Delivery • The Challenge Of Developing Inhalation Devices • Applying QbD Principles to Inhalation Therapies • Improving Patient Adherence With Product Design Fee: Standard Rate: $1,995- $2,495 depending on event Additional details will be posted as soon as they are available.
May 29 - 30, 2019 | Boston, Massachusetts
Skin Microbiome Congress is organized by Kisaco Research and will be held from May 29 - 30, 2019 at Boston, Massachusetts, United States of America. The target audience for this medical event is Multinational Beauty & Personal Care Companies, Multinational Pharmaceutical Companies, Skincare Brands & Biotechnology Companies, Formulators, Ingredients Suppliers & Packaging, Manufacturers, Sequencing Companies & Solution Providers. Discover the potential of prebiotic, probiotic and postbiotic products being developed to protect and promote a healthy microbiome and ultimately combat dermatological conditions from acne and eczema to dandruff and skin allergies. Take advantage of: • Effective Networking - Pre-schedule private meetings with any individual or company onsite using the online meeting scheduler application • Cutting Edge Research - Discover the latest advancement in therapeutic & cosmetic products containing live bacteria, bacterial extracts, or active ingredients to promote & protect the skins microbiome • Consumer Trends - Understand how consumers trends towards natural, organic products and active beauty are shaping the evolution of products adapted to the skin microbiome • Clinical Trials - Explore how to design an effective clinical trial & translate research into clinically & commercially viable therapeutics • Competitive Edge - Determine how to differentiate your product line & seize this market opportunity, gaining market share with scientifically backed products • Regulation - Understand the different paths to market & regulatory considerations necessary to launch a cosmetic or therapeutic product Additional details will be posted as soon as they are available.
Simulation-Based Anesthesia Training MOCA and Crisis Resource Management for Practicing Anesthesiologists (May 30, 2019)
May 30, 2019 | CME 7.50 | USD $1975 | Boston, Massachusetts
Simulation-Based Anesthesia Training MOCA and Crisis Resource Management for Practicing Anesthesiologists is organized by Center for Medical Simulation (CMS) and will be held on May 30, 2019 at Center For Medical Simulation, Boston, Massachusetts, United States of America. The target audience for this medical event is Anesthesiologists. This CME Conference has been approved for a maximum of 7.50 AMA PRA Category 1 Credits. Course Description : The Center for Medical Simulation (CMS) offers intensive one day workshops in Anesthesia Crisis Resource Management (ACRM) for all anesthesiologists that will meet the MOCA Part IV simulation requirement. CMS Anesthesia Crisis Resource Management workshops are designed for those anesthesiologists seeking to practice their skills in managing critical events. The overall focus of these workshops is on learning the type of teamwork and generic skills needed when managing any kind of infrequent but critical event in anesthesia, and opportunities will be made available to learn skills in managing certain specific events. During the workshops, participants requiring MOCA certification will each have a turn as the primary anesthesiologist caring for the patient. Additional details will be posted as soon as they are available.
May 30 - Jun 01, 2019 | AMA PRA Ca 18.00 | USD $825 | Boston, Massachusetts
Twenty-Third Annual Meeting: HIV Update: Contemporary Issues in Management is organized by Harvard Medical School (HMS) and will be held from May 30 - Jun 01, 2019 at Aloft Boston Seaport District, Boston, Massachusetts, United States of America. Who Should Attend? Whether you are a recent or an experienced provider of HIV care, this program is designed to educate providers at all levels, including: • Physicians specializing in Infectious Diseases, Primary Care, Family Practice, Internal Medicine, Hospitalists, Geriatrics, Gastroenterology, and Hepatology • PAs • Nurse Practitioners • Nurses • Pharmacists • Social Workers Accreditation: • 18 AMA PRA Category 1 Credits™ • 18 ABIM MOC Points • 6.25 Risk Management Credits • 18.4 Continuing Nurse Education Hours Description: Health care professionals can rely on this program for the latest updates and advances in the diagnosis and management of the HIV-infected patient For more than three decades, advances in medical knowledge and biomedical technology have fostered the evolution of HIV clinical care, but with more than 1.1 million people receiving treatment for HIV in the United States, the HIV epidemic continues to grow more complex, and health care professionals struggle to keep current on the latest developments and regimens. Along with adherence to lifelong antiretroviral therapy, today’s HIV-infected patient may also confront limitations in accessing care, renal, cardiovascular and liver diseases, other illnesses associated with aging, and coinfections with hepatitis B and/or C. Key topics include: • Diagnosing and managing HIV – tools for the primary care provider • Identifying optimal antiretroviral therapy (ART), treatment initiation, salvage therapy, and pre- and post-exposure prophylaxis and adherence to lifelong therapies • Integrating HIV management and opioid addiction treatment • Addressing opportunistic infections, dermatologic conditions, malignancies, and hepatitis B and C coinfections • Examining contemporary HIV topics including aging in the HIV population, renal, cardiovascular and liver diseases; and the management of HPV-related anogenital infection • Overcoming barriers in HIV for marginalized populations • Utilizing practical tools to address gender and sexual health challenges, including screening and treatment of sexually transmitted infections Why You Should Attend Increase your skills and knowledge to deliver unparalleled care to your patients. You will leave the course with: • The latest HIV knowledge, insight and teachings from leading authorities and clinical educators • A greater understanding of incorporating tools and tests into your practice • Awareness of your strengths and areas for improvement • A network of like-minded professional colleagues • An in-depth print and electronic syllabus packed with valuable information and real-world solutions Learning Objectives: At the end of this course, you will be able to: • Evaluate current data and guidelines on post-exposure and pre-exposure prophylaxis to prevent HIV infection • Recognize the clinical manifestations of HIV infection and describe recent advances in HIV testing • Integrate into practice recent advances in HIV care including tailoring antiretroviral therapy based on genotype, comorbidities and potential drug interactions, appropriate incorporation of newer antiretroviral agents into treatment regimens, approaches to initial treatment and salvage antiretroviral therapy, management of special populations, and appropriate management of common infections – opportunistic and otherwise • Counsel HIV-infected patients regarding antiretroviral therapy adherence and potential, long-term complications such as the risk for development of specific malignancies, chronic liver or renal disease, and chronic metabolic issues • Incorporate treatment approaches to address comorbidities and infectious complications • Determine which HIV-infected patients with hepatitis C virus (HCV) infection are candidates for HCV treatment with directly acting antivirals, design regimens and assessments of response, and describe drug-drug interactions, especially in HIV/HCV coinfected patients on antiretroviral therapy complications • Integrate treatments for substance use disorders into HIV care settings.
2019 Pharmacology Update for Dentists and Pharmacists: Opioids, Marijuana, Benzodiazepines, NSAIDS, Antibiotics & More - Newton
May 30, 2019 | Contact Hours 7.50 | USD $299.99 | Newton, Massachusetts
2019 Pharmacology Update for Dentists and Pharmacists: Opioids, Marijuana, Benzodiazepines, NSAIDS, Antibiotics & More is organized by PESI HealthCare and will be held on May 30, 2019 at Crowne Plaza Boston - Newton, Newton, Massachusetts, United States of America. This Conference has been approved for a maximum of 7.5 Contact Hours. Target Audience: • Dentists • Dental Hygienists • Dental Assistants • Dental Office Managers • Pharmacists • Pharmacy Technicians Conference Description: Did you know that 1 in 5 of your adult patients is currently using Marijuana? Are you aware that more than half of your patients have an SSRI prescription at home and the other half have either an opioid or benzodiazepine prescription at home before they ask you for medications? Do you have any idea what concurrent benzodiazepine, marijuana and/or SSRI use means to your medical and pharmacology decisions for these patients, or how you can best protect yourself from a malpractice suit with these patients? If you are unsure, then you can’t afford to miss this opportunity to join Dr. Eric Bornstein for this comprehensive pharmacology update. Dr. Bornstein will make sure you leave this program confident in your knowledge of new prescribing rules, new contra-indications, evidence-based antibiotic therapy and more. And, we’ll include free customizable opioid informed, consent forms and updated drug history forms. We guarantee you will leave this seminar prepared to protect your patient and yourself!. Conference Objectives: • Determine the 20 most common drugs that your dental patient may be taking with interactions and contraindications, including marijuana, new anticoagulants, new weight loss pills and nutritional supplements. • Evaluate clinically proven new and modern pain management principles and strategies mandated by the FDA and the CDC concerning opioids. • Analyze the dentist and hygienists role in understanding new resistant dental pathogens and new antibiotic regimens in the era of multi-drug resistant infections. • Assess new evidence concerning antibiotic prophylaxis regimens for your patients, and how this will affect you medical/legally. • Point out malpractice issues with prescribing opioids, antibiotics, and combinations of meds. • Integrate updated Customizable Opioid Informed Consent Forms and new updated Drug History Forms into your practice to satisfy government mandates and prevent malpractice claims. • Specify new anticoagulants, weight loss medications and nutritional supplements that your patients may be taking.
May 31, 2019 | Boston, Massachusetts
New England Ophthalmological Society (NEOS) Meeting is organized by New England Ophthalmological Society (NEOS) and will be held on May 31, 2019 at Back Bay Events Center, Boston, Massachusetts, United States of America. Additional details will be posted as soon as they are available.
May 31 - Jun 01, 2019 | CME 14.50 | USD $500 | Boston, Massachusetts
Update on Neurology and Psychiatry of Women - What Every Practitioner Needs to Know is organized by Harvard Medical School (HMS) and will be held from May 31 - Jun 01, 2019 at The Hale Building for Transformative Medicine, Boston, Massachusetts, United States of America. Target Audience: This course is targeted to Physicians, Psychologists, Physician Assistants, Nurses, Nurse Practitioners, and Family Practice Clinicians who practice in Anesthesiology, Family Medicine, Internal Medicine, Obstetrics and Gynecology, Psychiatry and Neurology, and/or Psychology and Mental Health. Accreditation: Physicians The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The Harvard Medical School designates this live activity for a maximum of 14.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nurse Practitioners and Registered Nurses For the purpose of recertification, the American Academy of Nurse Practitioners Certification Board and American Nurses Credentialing Center accept AMA PRA Category 1 Credit™ issued by organizations accredited by the ACCME (Accreditation Council for Continuing Medical Education). We would also suggest that learners check with their state licensing board to ensure they accept reciprocity with AMA PRA Category 1 Credit™ for re-licensure. Physician Assistants The National Commission on Certification of Physician Assistants (NCCPA) states that AMA PRA Category 1 Credits™ are acceptable for continuing medical education requirements for recertification. We would also suggest that learners check with their state licensing board to ensure they accept reciprocity with AMA PRA Category 1 Credit™ for re-licensure. Canadian Accreditation The Royal College of Physicians and Surgeons of Canada recognizes conferences and workshops held outside of Canada that are developed by a university, academy, hospital, specialty society or college as accredited group learning activities. European Accreditation Through an agreement between the American Medical Association and the European Union of Medical Specialists, physicians may convert AMA PRA Category 1 Credits™ to an equivalent number of European CME Credits® (ECMEC®s). Information on the process of converting AMA PRA Category 1 Credits™ to ECMEC®s can be found at: www.eaccme.eu. Course Description: This course will educate participants about issues specific to women with neurological and psychiatric disease. The presentations will focus on sex and gender differences of neurological and psychiatric conditions across all stages of women’s lives - from menarche through pregnancy/postpartum and menopause. The course is designed to address the continuing education needs of all physicians including, but not limited to, those in neurology, psychiatry, internal medicine and obstetrics. The presentations will provide high quality, leading-edge content focusing on evidence based clinical approach and up to date research on women’s health and gender-specific care in both neurology and psychiatry. Interactive learning formats including case-based presentations and Q&A will be utilized to allow learners to engage in the educational process. Learning Objectives: Upon completion of this activity, participants will be able to: • Utilize the information presented to recommend appropriate gender specific treatment and management of many neurologic and psychiatric diseases including stroke, bipolar disease, depression, headache, conversion disorders, and epilepsy. • Evaluate treatment strategies for conditions across your female patient’s life cycle. • Develop strategies to treat sexual and urologic dysfunction in women. • Apply appropriate guidelines for the treatment of neurologic and psychiatric diseases in women.
May 31, 2019 | CE 7.00 | USD $295 | Boston, Massachusetts
14th Head and Neck Cancer Symposium is organized by Tufts University School of Dental Medicine and will be held on May 31, 2019 at Tufts University School of Dental Medicine, Boston, Massachusetts, United States of America. This CE Conference has been approved for a maximum of 7 Credit Hours. Description Oral cancer remains the most common disfiguring and deadly disease that oral health care providers, including general dentists, specialists, physicians and staff, encounter in practice. This course provides clinicians with the knowledge to understand the various etiologic factors of oral cancer, and enhances their ability to recognize early potentially malignant and malignant changes within the oral cavity. Course attendees will learn to effectively communicate with their patients regarding appropriate management. This course also discusses the complex nature of such treatment and the complications that may ensue, as well as their potential to affect dental treatment. Objectives • Name conventional and newly-recognized factors for oropharyngeal and oral cancer, including human papillomavirus infection • List the oral complications of oral cancer therapy and their implications for oral health care providers • Outline a management strategy for patients with advanced stage oral cancer • Define the complications associated with the surgical and medical management of head and neck cancer